X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6381) 6381
Publication (455) 455
Book Review (89) 89
Book Chapter (47) 47
Conference Proceeding (18) 18
Dissertation (7) 7
Magazine Article (7) 7
Book / eBook (4) 4
Web Resource (4) 4
Data Set (3) 3
Paper (3) 3
Government Document (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4188) 4188
index medicus (3521) 3521
diabetes mellitus, type 2 - drug therapy (2287) 2287
animals (2145) 2145
male (2082) 2082
dipeptidyl-peptidase iv inhibitors - therapeutic use (1777) 1777
female (1536) 1536
type 2 diabetes (1489) 1489
endocrinology & metabolism (1404) 1404
hypoglycemic agents - therapeutic use (1398) 1398
diabetes (1290) 1290
glucagon-like peptide-1 (1236) 1236
dipeptidyl peptidase 4 - metabolism (1184) 1184
middle aged (1124) 1124
pharmacology & pharmacy (1016) 1016
dipeptidyl-peptidase iv inhibitors - pharmacology (991) 991
aged (881) 881
sitagliptin (854) 854
rats (824) 824
mice (790) 790
glucose (746) 746
dipeptidyl-peptidase iv inhibitors - adverse effects (733) 733
adult (704) 704
dipeptidyl peptidase-4 inhibitor (692) 692
biochemistry & molecular biology (683) 683
treatment outcome (676) 676
diabetes mellitus, type 2 - blood (670) 670
adamantane - analogs & derivatives (667) 667
analysis (615) 615
insulin (599) 599
metformin (589) 589
double-blind (587) 587
glycemic control (583) 583
hypoglycemic agents - adverse effects (581) 581
blood glucose - metabolism (576) 576
hypoglycemic agents (576) 576
diabetes mellitus (568) 568
dipeptidyl peptidase-iv (553) 553
dipeptidyl-peptidase iv inhibitors - administration & dosage (548) 548
sitagliptin phosphate (544) 544
dipeptidyl peptidase iv (529) 529
dipeptidyl-peptidase-iv (526) 526
hypoglycemic agents - pharmacology (521) 521
drug therapy, combination (514) 514
vildagliptin (508) 508
care and treatment (504) 504
blood glucose - drug effects (492) 492
research (492) 492
hypoglycemic agents - administration & dosage (456) 456
type-2 diabetes-mellitus (452) 452
risk factors (435) 435
dipeptidyl peptidase-4 inhibitors (426) 426
peptides (423) 423
glp-1 (413) 413
peptidase (411) 411
internal medicine (407) 407
dipeptidyl-peptidase iv inhibitors (405) 405
type 2 diabetes mellitus (404) 404
cd26 (403) 403
drug therapy (403) 403
expression (401) 401
safety (399) 399
metformin - therapeutic use (397) 397
chemistry, medicinal (388) 388
dipeptidyl peptidase 4 (384) 384
adamantane - therapeutic use (371) 371
beta-cell function (371) 371
diabetes therapy (370) 370
efficacy (370) 370
diabetes mellitus, type 2 - complications (368) 368
dextrose (362) 362
glucagon (361) 361
inhibitors (357) 357
dpp-4 inhibitor (356) 356
diabetes mellitus, type 2 - metabolism (349) 349
medicine, general & internal (348) 348
glycated hemoglobin a - metabolism (343) 343
triazoles - therapeutic use (330) 330
enzymes (324) 324
health aspects (324) 324
pyrazines - therapeutic use (324) 324
mellitus (317) 317
medicine, research & experimental (314) 314
medicine & public health (312) 312
double-blind method (303) 303
insulin resistance (302) 302
physiological aspects (301) 301
proteins (300) 300
cell biology (296) 296
dose-response relationship, drug (293) 293
linagliptin (293) 293
therapy (291) 291
dipeptidyl peptidase 4 - chemistry (287) 287
abridged index medicus (285) 285
hyperglycemia (283) 283
improves glycemic control (281) 281
inflammation (279) 279
proteases (279) 279
clinical trials (271) 271
cardiac & cardiovascular systems (268) 268
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6178) 6178
Japanese (54) 54
German (49) 49
French (38) 38
Spanish (28) 28
Chinese (21) 21
Korean (19) 19
Hungarian (11) 11
Russian (10) 10
Czech (8) 8
Italian (7) 7
Danish (4) 4
Dutch (3) 3
Polish (3) 3
Portuguese (2) 2
Croatian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Therapeutics, ISSN 0149-2918, 2014, Volume 36, Issue 12, pp. 2072 - 2079
Abstract Purpose Although recent reports suggest an association between saxagliptin and an increased risk of admissions for heart failure, it is not clear... 
Internal Medicine | Medical Education | DPP-IV inhibition | cardiovascular disease | heart failure | type 2 diabetes | Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care (EXAMINE) | Vildagliptin in Ventricular Dysfunction Diabetes Trial (VIVIDD) | Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 trial | Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus-Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 trial | MYOCARDIAL-INFARCTION | SAXAGLIPTIN | HUMANS | Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 trial | IMPACT | CLINICAL-TRIALS | IMPROVES | PHARMACOLOGY & PHARMACY | TYPE-2 DIABETES-MELLITUS | CARDIOVASCULAR RISK | Dipeptides - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptides - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Pyrrolidines - adverse effects | Uracil - therapeutic use | Hospitalization | Pyrrolidines - therapeutic use | Uracil - adverse effects | Piperidines - therapeutic use | Piperidines - adverse effects | Adamantane - therapeutic use | Sitagliptin Phosphate - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Nitriles - adverse effects | Heart Failure - chemically induced | Adamantane - adverse effects | Adamantane - analogs & derivatives | Nitriles - therapeutic use | Sitagliptin Phosphate - adverse effects | Uracil - analogs & derivatives | Heart failure | Regulatory agencies | Heart attacks | Peptides | Mortality | Cardiovascular disease | FDA approval | Patients | Data bases | Studies | Diabetes | Drug therapy | Acute coronary syndromes
Journal Article
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 06/2018, Volume 78, Issue 6, pp. 1090 - 1096
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 02/2012, Volume 340, Issue 2, pp. 248 - 255
Dipeptidyl peptidase (DPP) IV inhibitors are probably beneficial for preventing diabetic complication and modulating glucagon-like peptide-1 receptor (GLP-1R)... 
FIBROSIS | GROWTH-FACTOR-BETA | TGF-BETA | GLP-1 | GLUCAGON-LIKE PEPTIDE-1 | GLUCOSE-METABOLISM | BETA-CELL APOPTOSIS | RECEPTOR EXPRESSION | IMPROVES | PHARMACOLOGY & PHARMACY | NEPHROPATHY | Diabetes Mellitus, Experimental - drug therapy | Dipeptidyl Peptidase 4 - metabolism | Gene Expression - drug effects | Kidney - pathology | Gene Expression - genetics | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Transforming Growth Factor beta1 - metabolism | Caspase 3 - metabolism | Body Weight - drug effects | Diabetic Nephropathies - drug therapy | Pyrrolidines - administration & dosage | Glucagon-Like Peptide 1 - blood | Male | Insulin - blood | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Pyrrolidines - pharmacology | Pyrrolidines - therapeutic use | Kidney - metabolism | Diabetic Nephropathies - physiopathology | Glomerular Basement Membrane - pathology | Adamantane - therapeutic use | Diabetes Mellitus, Experimental - complications | Adamantane - administration & dosage | Cyclic AMP - urine | Deoxyguanosine - analogs & derivatives | Kidney - physiopathology | Adamantane - analogs & derivatives | Diabetes Mellitus, Experimental - physiopathology | Receptors, Glucagon - genetics | Adamantane - pharmacology | Diabetic Nephropathies - pathology | Kidney - drug effects | Deoxyguanosine - urine | Diabetic Nephropathies - metabolism | Rats | Receptors, Glucagon - metabolism | Rats, Sprague-Dawley | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Blood Glucose - drug effects | Eating - drug effects | Glomerular Basement Membrane - drug effects | Animals | Glucagon-Like Peptide-1 Receptor | Diabetes Mellitus, Experimental - pathology | Blood Glucose - metabolism
Journal Article
Trends in Food Science & Technology, ISSN 0924-2244, 08/2016, Volume 54, pp. 1 - 16
Journal Article
Handbook of Experimental Pharmacology, ISSN 0171-2004, 2011, Volume 203, Issue 203, pp. 53 - 74
Conference Proceeding
Current Medical Research and Opinion, ISSN 0300-7995, 10/2018, Volume 34, Issue 10, pp. 1849 - 1854
Objectives: This analysis of real-world data aimed to (a) determine the proportion of Type II diabetes (T2DM) patients treated with metformin or dipeptidyl... 
metformin | type 2 | chronic | dipeptidyl-peptidase IV inhibitors | Diabetes mellitus | renal insufficiency | MEDICINE, RESEARCH & EXPERIMENTAL | MODERATE | MANAGEMENT | MELLITUS | PREVALENCE | IMPAIRMENT | MEDICINE, GENERAL & INTERNAL | DPP-4 INHIBITORS | CHRONIC KIDNEY-DISEASE
Journal Article